Improvement in Impaired Social Cognition but Not Seizures by Everolimus in a Child with Tuberous Sclerosis-Associated Autism through Increased Serum Antioxidant Proteins and Oxidant/Antioxidant Status

We investigated the effect of the mammalian target of rapamycin (mTOR) inhibitor everolimus on tuberous sclerosis complex- (TSC-) associated autistic symptoms and focal seizures with impaired awareness in a female child with TSC. We further evaluated the relationship between improved autistic sympto...

Descripción completa

Detalles Bibliográficos
Autores principales: Yui, Kunio, Imataka, George, Sasaki, Hitomi, Kawasaki, Yohei, Okanshi, Tohru, Shiroki, Ryoichi, Yoshihara, Shigemi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6907049/
https://www.ncbi.nlm.nih.gov/pubmed/31871809
http://dx.doi.org/10.1155/2019/2070619

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6907049/
https://www.ncbi.nlm.nih.gov/pubmed/31871809
http://dx.doi.org/10.1155/2019/2070619

Ejemplares similares